Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. In research models it is used to study incretin biology, metabolic regulation, and the integrated control of glucose homeostasis, appetite signaling, and energy balance.
Tirzepatide is a research-grade, long-acting incretin-based peptide engineered to engage both GIP and GLP-1 receptors, enabling simultaneous interrogation of two key metabolic signaling pathways. Its dual-agonist profile makes it a valuable tool for studying endocrine cross-talk, insulin signaling dynamics, and appetite- and weight-regulation mechanisms beyond single-receptor incretin analogues.
Research SignificanceDual activation of GIP and GLP-1 receptors for integrated incretin-pathway studiesEnables investigation of glucose regulation, insulin sensitivity, and β-cell signalingSupports research into appetite control, satiety signaling, and energy-balance mechanismsUseful for comparative studies versus single-agonist GLP-1–based peptides
Potential Research ApplicationsMetabolic and endocrine pathway researchModels of glucose homeostasis and insulin signalingAppetite, satiety, and energy-expenditure investigationsStructure–activity and receptor-bias studies of incretin mimetics
SpecificationsForm: Lyophilized peptide powderIdentity: Synthetic dual GIP/GLP-1 receptor agonist peptide
Storage: Store at −20 °C; once reconstituted, use promptly under sterile laboratory conditions
